Records 1 - 14 (of 14 Records)
|Query Trace: Neoplasms and meta-analysis and ALK[original query]|
| Clinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancer.
PloS one 2013 8 (1): 1.
Li Y, Li Y, Yang T, Wei S, Wang J, Wang M, Wang Y, Zhou Q, Liu H, Chen J
| A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.
Molecular cancer therapeutics 2014 Jul 13 (7): 1918-28.
Xia Junfeng, Jia Peilin, Hutchinson Katherine E, Dahlman Kimberly B, Johnson Douglas, Sosman Jeffrey, Pao William, Zhao Zhongmi
| Clinicopathologic features of patients with non-small cell lung cancer harboring the EML4-ALK fusion gene: a meta-analysis.
PloS one 2014 9 (10): e110617.
Wang Ying, Wang Shumin, Xu Shiguang, Qu Jiaqi, Liu
| Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers.
Lung cancer (Amsterdam, Netherlands) 2016 Dec 102 122-134.
Chapman Aaron M, Sun Kathie Y, Ruestow Peter, Cowan Dallas M, Madl Amy
| Anaplastic lymphoma kinase gene rearrangement predicts better prognosis in NSCLC patients: A meta-analysis.
Lung cancer (Amsterdam, Netherlands) 2017 Oct 112 1-9.
Wang Zili, Yang Haitao, Luo Shuimei, Liu Bo, Zhang Nianhai, Li Lina, Zhou Sijing, Shen Ruifen, Xie Xian
| Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis.
Oncotarget 2018 Jan 9 (7): 7684-7699.
Lan Bo, Ma Chengxi, Zhang Chengyan, Chai Shoujie, Wang Pingli, Ding Liren, Wang K
| Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
BMC cancer 2020 4 20 (1): 328.
Qin Kang, Hou Helei, Liang Yu, Zhang Xiaoch
| Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis.
Pathology, research and practice 2021 Jul 224 153551.
Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih
| Crizotinib Versus Conventional Chemotherapy in First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Oncology and therapy 2021 6 9 (2): 505-524.
Cruz Barbara D, Barbosa Mariana M, Torres Lucas L, Azevedo Pamela S, Silva Vânia E A, Godman Brian, Alvares-Teodoro Julia
| Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Frontiers in oncology 2021 5 11 680191.
Qian Xiaohan, Fu Mengjiao, Zheng Jing, Zhou Jianya, Zhou Jianyi
| Prevalence of Targetable Mutations in Black Patients With Lung Cancer: A Systematic Review and Meta-Analysis.
JCO oncology practice 2021 May 17 (5): e629-e636.
Costa Philippos A, Saul Eduardo E, Paul Yonette, Iyer Sunil, da Silva Laercio Lopes, Tamariz Leonardo, Lopes Gilber
| Computed tomography-guided lung biopsy for molecular tests: a meta-analysis.
Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery 2022 Jun 19 (2): 96-101.
Zhang Jian-Hua, Xia Feng-Fei, Yang Xiao-Shan, Li
| Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis.
Thrombosis research 2022 3 213 47-56.
Abufarhaneh Mohammed, Pandya Rudra Kashyap, Alkhaja Ahmed, Iansavichene Alla, Welch Stephen, Lazo-Langner Alejand
| RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis.
Frontiers in oncology 2022 12 12 1024833.
Wu Min, Jiang Jun, Zhang Xuewen, Chen Jie, Chang Qiaomei, Chen Ro